Drug Channels Institute (DCI) is a leading provider of specialized management education and computer-based training for and about the pharmaceutical industry. >

E-LEARNING MODULES

DCI delivers educational solutions for clients that enhance the business acumen of employees, from senior executives to field reps to internal operations. State-of-the-art instructional design, coupled with extensive industry knowledge, allows DCI to build rigorous programs with accurate, fact-based content reflecting the latest developments. Even better, we deliver the material in an engaging, accessible manner using turn-key technology solutions. View samples of our modules

View Sample

Industry Reports

2013-14 Economic Report on Retail, Mail, and Specialty Pharmacies

This completely updated, revised, and expanded of the $287 billion U.S. pharmacy industry thoroughly dissects its interactions with the U.S. healthcare system. more >

2014-15 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

The $300 billion U.S. drug wholesaling industry is undergoing dramatic change. Understanding the implications of the industry’s evolution has never been more crucial. more >

From The Drug Channels Blog

Surprise? Once Again, FULs and AMP Final Rule Delayed

In what has become a semi-annual ritual, the Centers for Medicare & Medicaid Services (CMS) last night announced plans to delay the Federal Upper Limits (FUL) and the Final Rule more >

News Roundup, November 2014: Salix, Merck, Co-Pay Cards, Part D Preferred Networks, and an Insurance Cartoon

Here's a pre-Thanksgiving news roundup, to stretch your mind before stretching your stomach next week. In this issue:Stuffing—Salix Pharmaceuticals reminds investors why wholesaler agreements matterPumpkin Pie (in the Face)—How Merck more >